01/29/2026
I recently had the opportunity to attend the American Professional Society of ADHD and Related Disorders conference in San Diego—and it was four days of deep, evidence-based learning that directly impacts how I care for ADHD clients.
APSARD is dedicated to improving the quality of care for individuals with ADHD across the lifespan. This is where research is shared before it reaches textbooks—and where clinicians recalibrate what they think they know.
At APSARD:
• ADHD diagnostic criteria are debated and refined
• Medication research is presented early
• Comorbidities like trauma, autism, mood disorders, and substance use are clarified
This matters because ADHD is still widely misunderstood—even by clinicians.
Many providers were trained using childhood-centric models, behavior-only frameworks, or tests that don’t reflect real-world impairment.
APSARD directly addresses why ADHD is a performance disorder—not a motivation problem—and why executive function collapses under stress, even when someone “knows what to do.”
Attending conferences like this improves diagnostic accuracy, ethical care, and real-world outcomes. It reduces misdiagnosis, minimizes shame, and leads to more targeted, compassionate treatment.
This isn’t about being “more informed.”
It’s about being less harmful—and more effective.
I can’t wait to share what I learned. Stay tuned. 💙
Teaser: Many people are told they need expensive neuropsych testing to diagnose ADHD—but research says otherwise.
In most cases, ADHD can be accurately diagnosed without full neuropsych testing.
Stay tuned—this could save you a lot of unnecessary cost and confusion.
💜Dr. Shawn